IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIE BERNADETTE CASNE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1194456384
CMS profile
11367446
Location
HURRICANE, WV

General Payments · PY2022–2024

$2,386.45

  • Reported across 129 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,022.89

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health WV All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,022.89 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $358.49 19
Janssen Pharmaceuticals, Inc $148.89 10
ABBVIE INC. $142.43 10
Neurocrine BioSciences, Inc. $124.97 1
Lundbeck LLC $88.50 4
Alkermes, Inc. $36.52 2
ITI, Inc. $31.15 2
Vanda Pharmaceuticals Inc. $21.48 1
Teva Pharmaceuticals USA, Inc. $20.02 1
Takeda Pharmaceuticals U.S.A., Inc. $19.01 1
Axsome Therapeutics, Inc. $17.72 1
Indivior Inc. $13.71 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $166.00 8
PY2023 $1,197.56 68
PY2024 $1,022.89 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.09 02/22/2024 Food and Beverage Undisputed 01/23/2026 1106890435 CMS
ABBVIE INC. $5.27 04/26/2024 Food and Beverage Undisputed 01/23/2026 1106890437 CMS
ABBVIE INC. $17.26 04/30/2024 Food and Beverage Undisputed 01/23/2026 1106890439 CMS
ABBVIE INC. $5.19 05/08/2024 Food and Beverage Undisputed 01/23/2026 1106890441 CMS
ABBVIE INC. $12.66 06/13/2024 Food and Beverage Undisputed 01/23/2026 1106890443 CMS
ABBVIE INC. $31.32 08/06/2024 Food and Beverage Undisputed 01/23/2026 1106890445 CMS
ABBVIE INC. $21.40 08/14/2024 Food and Beverage Undisputed 01/23/2026 1106890447 CMS
ABBVIE INC. $6.79 10/09/2024 Food and Beverage Undisputed 01/23/2026 1106890449 CMS
ABBVIE INC. $18.45 11/07/2024 Food and Beverage Undisputed 01/23/2026 1106890451 CMS
ABBVIE INC. $5.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1106890453 CMS
Alkermes, Inc. $16.29 01/12/2024 Food and Beverage Undisputed 01/23/2026 1120477046 CMS
Alkermes, Inc. $20.23 05/09/2024 Food and Beverage Undisputed 01/23/2026 1120477048 CMS
Axsome Therapeutics, Inc. $17.72 02/02/2024 Food and Beverage Undisputed 01/23/2026 1148388702 CMS
Indivior Inc. $13.71 03/11/2024 Food and Beverage Undisputed 01/23/2026 1144546987 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.05 02/01/2024 Food and Beverage Undisputed 01/23/2026 1143400680 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.10 03/13/2024 Food and Beverage Undisputed 01/23/2026 1143400683 CMS
Janssen Pharmaceuticals, Inc $5.65 02/16/2024 Food and Beverage Undisputed 01/23/2026 1078250481 CMS
Janssen Pharmaceuticals, Inc $8.65 03/15/2024 Food and Beverage Undisputed 01/23/2026 1078250465 CMS
Janssen Pharmaceuticals, Inc $12.62 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078250477 CMS
Janssen Pharmaceuticals, Inc $12.37 07/12/2024 Food and Beverage Undisputed 01/23/2026 1078250469 CMS
Janssen Pharmaceuticals, Inc $8.55 08/16/2024 Food and Beverage Undisputed 01/23/2026 1078250463 CMS
Janssen Pharmaceuticals, Inc $9.18 09/20/2024 Food and Beverage Undisputed 01/23/2026 1078250461 CMS
Janssen Pharmaceuticals, Inc $7.39 10/18/2024 Food and Beverage Undisputed 01/23/2026 1078250459 CMS
Janssen Pharmaceuticals, Inc $8.58 11/01/2024 Food and Beverage Undisputed 01/23/2026 1078250457 CMS
Janssen Pharmaceuticals, Inc $66.07 11/07/2024 Food and Beverage Undisputed 01/23/2026 1078250483 CMS
Janssen Pharmaceuticals, Inc $9.83 12/13/2024 Food and Beverage Undisputed 01/23/2026 1078250479 CMS
Lundbeck LLC $25.37 01/26/2024 Food and Beverage Undisputed 01/23/2026 1146003634 CMS
Lundbeck LLC $26.78 02/10/2024 Food and Beverage Undisputed 01/23/2026 1146003636 CMS
Lundbeck LLC $16.61 03/28/2024 Food and Beverage Undisputed 01/23/2026 1146003638 CMS
Lundbeck LLC $19.74 07/30/2024 Food and Beverage Undisputed 01/23/2026 1146003640 CMS
Neurocrine Biosciences, Inc. $124.97 10/17/2024 Food and Beverage Undisputed 01/23/2026 1150921289 CMS
Otsuka America Pharmaceutical, Inc. $5.80 01/12/2024 Food and Beverage Undisputed 01/23/2026 1119041557 CMS
Otsuka America Pharmaceutical, Inc. $10.16 03/07/2024 Food and Beverage Undisputed 01/23/2026 1119041559 CMS
Otsuka America Pharmaceutical, Inc. $17.85 03/27/2024 Food and Beverage Undisputed 01/23/2026 1119041561 CMS
Otsuka America Pharmaceutical, Inc. $6.77 03/29/2024 Food and Beverage Undisputed 01/23/2026 1119041563 CMS
Otsuka America Pharmaceutical, Inc. $5.05 04/05/2024 Food and Beverage Undisputed 01/23/2026 1119041565 CMS
Otsuka America Pharmaceutical, Inc. $16.09 04/15/2024 Food and Beverage Undisputed 01/23/2026 1119041567 CMS
Otsuka America Pharmaceutical, Inc. $22.20 04/23/2024 Food and Beverage Undisputed 01/23/2026 1119041569 CMS
Otsuka America Pharmaceutical, Inc. $15.76 04/30/2024 Food and Beverage Undisputed 01/23/2026 1119041571 CMS
Otsuka America Pharmaceutical, Inc. $7.77 06/04/2024 Food and Beverage Undisputed 01/23/2026 1119041573 CMS
Otsuka America Pharmaceutical, Inc. $3.45 06/27/2024 Food and Beverage Undisputed 01/23/2026 1119041575 CMS
Otsuka America Pharmaceutical, Inc. $7.33 08/02/2024 Food and Beverage Undisputed 01/23/2026 1119041577 CMS
Otsuka America Pharmaceutical, Inc. $10.71 09/18/2024 Food and Beverage Undisputed 01/23/2026 1119041579 CMS
Otsuka America Pharmaceutical, Inc. $24.27 10/16/2024 Food and Beverage Undisputed 01/23/2026 1119041581 CMS
Otsuka America Pharmaceutical, Inc. $8.64 10/29/2024 Food and Beverage Undisputed 01/23/2026 1119041583 CMS
Otsuka America Pharmaceutical, Inc. $78.36 11/14/2024 Food and Beverage Undisputed 01/23/2026 1119041585 CMS
Otsuka America Pharmaceutical, Inc. $9.02 11/21/2024 Food and Beverage Undisputed 01/23/2026 1119041587 CMS
Otsuka America Pharmaceutical, Inc. $4.75 11/22/2024 Food and Beverage Undisputed 01/23/2026 1119041589 CMS
Otsuka America Pharmaceutical, Inc. $16.23 12/02/2024 Food and Beverage Undisputed 01/23/2026 1119041591 CMS
Otsuka America Pharmaceutical, Inc. $88.28 12/10/2024 Food and Beverage Undisputed 01/23/2026 1119041593 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.01 05/23/2024 Food and Beverage Undisputed 01/23/2026 1137723584 CMS
Teva Pharmaceuticals USA, Inc. $20.02 01/18/2024 Food and Beverage Undisputed 01/23/2026 1151721198 CMS
Vanda Pharmaceuticals Inc. $21.48 09/04/2024 Food and Beverage Undisputed 01/23/2026 1133935224 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.